The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Two current Tri-Institutional MD-PhD Students have been selected as members of the Weill Cornell Medical College Chapter of Alpha Omega Alpha Honor Medical Society. Andrew Gregg and Maria Sacta, both currently completing their final clinical training in the Program, were chosen  to be among the 17 students comprising the WCMC AΩA 2019 class. Both students defended their PhD theses in 2017 and will be graduating from the MD-PhD program this academic year. 
Tri-I MD-PhD student Sarah Schrader has been awarded an F30 fellowship from the National Institutes of Health, National Institute of Allergy and Infectious Diseases for her work on elucidating mechanisms of antibiotic tolerance in Mycobacteria in Weill Cornell Medicine's Nathan Lab.